Apr. 17, 2026
CAMP4 grants options for 43,000 shares to new hires
Granted April 15, the options carry a 10-year term and vest over four years, tying pay to continued service.
Apr. 16, 2026
MPE Partners and SKB Cases Acquire NANUK Gear Protection
The acquisition combines two leading protective case manufacturers to drive growth and innovation.
Apr. 15, 2026
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies
New biotech company aims to transform care for people living with autoimmune and inflammatory diseases
Apr. 15, 2026
Divert Secures Strategic Partnership with Mitsubishi
Partnership combines strategic capital investment and renewable natural gas offtake arrangement, advancing Divert to a valuation of over $1 billion.
Apr. 14, 2026
Kailera Aims For Up To $533M+ Nasdaq IPO To Support China-Derived Obesity Drug Pipeline
Biotech firm targets major public offering to fund late-stage trials for lead obesity therapy
Apr. 14, 2026
Leal Therapeutics Bolsters Leadership Team
Biotech firm adds Chief Medical Officer and Chief Business Officer to advance CNS drug pipeline.
Apr. 14, 2026
Cell Therapy Biotech Obsidian Merges with Galera to Go Public
The combined company will operate as Obsidian Therapeutics and trade on Nasdaq under the ticker 'OBX'.
Apr. 14, 2026
Galera and Obsidian Announce $350M Merger, Advancing Novel TIL Therapies
Combined company to focus on Obsidian's pipeline of engineered tumor infiltrating lymphocyte (TIL) cell therapies.
Apr. 14, 2026
OS Therapies Appoints Moderna Co-Founder to Strategic Advisory Board
Dr. Robert Langer, a renowned biotech pioneer, will advise on the company's oncology pipeline and drug development.
Apr. 14, 2026
Mudra Celebrates Five Years as the Leading Liquidity Locker and Token Locker on BNB Chain
Over 150,000 Liquidity Locks Processed, 10,000+ Projects Served, and a Flawless Five-Year Track Record — Mudra's PancakeSwap Locker and BNB Chain Locker Continue to Set the Standard for DeFi Trust Infrastructure
